| 10141 |
Intraperitoneal Lidocaine Instillation and Postcesarean Pain After Parietal Peritoneal Closure A Randomized Double Blind Placebo-controlled Trial |
Department of Anesthesia and Intensive Care |
2010 |
| 10142 |
Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial.
|
Department of Obstetrics and Gynecology |
2010 |
| 10143 |
Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial.
|
Department of Obstetrics and Gynecology |
2010 |
| 10144 |
Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial.
|
Department of Obstetrics and Gynecology |
2010 |
| 10145 |
Intravenous propacetamol as postoperative analgesia in cesarean section comparative study with intra-thecal morphine. |
Department of Anesthesia and Intensive Care |
2010 |
| 10146 |
Iron Chelation Therapy in Upper Egyptian Transfusion dependent Pediatric Homozygous b-Thalassemia Major. Impact on Serum L-Carnitine/Free Fatty Acids, Osteoprotegerin/ The Soluble Receptor Activator of Nuclear Factor-kB Ligand Systems, and Bone Mineral De |
Department of Medical Physiology |
2010 |
| 10147 |
Iron Chelation Therapy in Upper Egyptian Transfusion dependent Pediatric Homozygous b-Thalassemia Major. Impact on Serum L-Carnitine/Free Fatty Acids, Osteoprotegerin/ The Soluble Receptor Activator of Nuclear Factor-kB Ligand Systems, and Bone Mineral De |
Department of Medical Physiology |
2010 |
| 10148 |
Iron Chelation Therapy in Upper Egyptian Transfusion-dependent Pediatric Homozygous beta-Thalassemia Major Impact on Serum L-Carnitine/Free Fatty Acids, Osteoprotegerin/The Soluble Receptor Activator of Nuclear Factor-kappa beta Ligand Systems, and Bone M |
Department of Medical Physiology |
2010 |
| 10149 |
Iron Chelation Therapy in Upper Egyptian Transfusion-dependent Pediatric Homozygous beta-Thalassemia Major Impact on Serum L-Carnitine/Free Fatty Acids, Osteoprotegerin/The Soluble Receptor Activator of Nuclear Factor-kappa beta Ligand Systems, and Bone M |
Department of Pediatrics |
2010 |
| 10150 |
Iron Chelation Therapy in Upper Egyptian Transfusion-dependent Pediatric Homozygous beta-Thalassemia Major Impact on Serum L-Carnitine/Free Fatty Acids, Osteoprotegerin/The Soluble Receptor Activator of Nuclear Factor-kappa beta Ligand Systems, and Bone M |
Department of Biochemistry |
2010 |